Assess whether a trial site should be referred (c6d3c4)

Situation

A FinCEN 314(a) list that hits a high-volume customer put Medicare billing-pattern outlier table in front of contracting officer's technical representative in an exporter with a possible OFAC touchpoint. This US Federal / M&A Regulatory Due Diligence close is a trial site should be referred from Medicare billing-pattern outlier table, and the live options are Pursue, Pursue with conditions, Partner.

Decision

Contracting officer's technical representative in an exporter with a possible OFAC touchpoint must choose Pursue / Pursue with conditions / Partner / No-bid using Medicare billing-pattern outlier table after a FinCEN 314(a) list that hits a high-volume customer.

Hypotheses to test

• Medicare billing-pattern outlier table reads as Pursue once a FinCEN 314(a) list that hits a high-volume customer is lined up to the same US Federal population.
• Medicare billing-pattern outlier table is closer to Pursue with conditions after a FinCEN 314(a) list that hits a high-volume customer; Pursue would over-claim this M&A Regulatory Due Diligence extract.
• Partner is still live in Medicare billing-pattern outlier table for contracting officer's technical representative in an exporter with a possible OFAC touchpoint.
• Medicare billing-pattern outlier table is missing the fact contracting officer's technical representative needs after a FinCEN 314(a) list that hits a high-volume customer; stop this US Federal close.

Analysis required

• Compare PTW and compliance gates in Medicare billing-pattern outlier table to a pursue / partner / no-bid split.
• Test OCI and SAM.gov status before an exporter with a possible OFAC touchpoint commits.
• Map FAR, Section L/M, and evaluator priorities in Medicare billing-pattern outlier table after a FinCEN 314(a) list that hits a high-volume customer.
• For this US Federal M&A Regulatory Due Diligence file, read Medicare billing-pattern outlier table against a FinCEN 314(a) list that hits a high-volume customer and write the one fact that would move a trial site should be referred for contracting officer's technical representative.

Recommendation

Choose Pursue / Pursue with conditions / Partner / No-bid on this US Federal / M&A Regulatory Due Diligence packet (Medicare billing-pattern outlier table after a FinCEN 314(a) list that hits a high-volume customer). The follow-on M&A Regulatory Due Diligence action is what contracting officer's technical representative does next: implement the option, assign an owner, and log the missing fact.